Timothy Vreeland, MD
Surgical Oncology · Saint Louis, MONPI 1497982771
Payments from drug & device makers
What this record shows
It is spread thinly across 23 manufacturers, the largest accounting for just 22.8%. Reporting peaked in 2019 at $1,947 and has fallen 61.6% since, to $748 in 2025.
Across 58 payments — averaging $77.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- Histosonics, Inc.$945
- Medical Device Business Services, Inc.$922
- Johnson & Johnson$277
- Dilon Technologies, Inc.$247
- Integra Lifesciences Corporation$176
- plus $899 from 17 others
What the payments were for
- Travel & lodging$2,33552%
- Food & beverage$2,15748%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 16 | $1,026 |
| Histosonics, Inc. | 5 | $945 |
| Medical Device Business Services, Inc. | 7 | $922 |
| Johnson & Johnson(2 entities) | 4 | $277 |
| Dilon Technologies, Inc. | 2 | $247 |
| Integra Lifesciences Corporation | 2 | $176 |
| Intera Oncology, Inc | 1 | $175 |
| Hologic Sales And Service, LLC | 2 | $124 |
| Regeneron Healthcare Solutions, Inc. | 1 | $123 |
| Tempus AI, Inc | 1 | $119 |
| ETS Wound Care LLC | 4 | $71 |
| Myriad Genetic Laboratories, Inc. | 2 | $44 |
| Tersera Therapeutics LLC | 1 | $32 |
| Daiichi Sankyo Inc. | 1 | $28 |
| AstraZeneca | 1 | $24 |
| Merck | 1 | $23 |
| Springworks Therapeutics, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Pfizer | 1 | $20 |
| Syndax Pharmaceuticals, Inc. | 1 | $20 |
| Spectrum Pharmaceuticals Inc. | 1 | $17 |
| Stryker | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ATTUNE$851
- Da Vinci Surgical System$795
- HemoBlast Bellows$247
- INTERA$175
- NON APPLICABLE$139
- Certus 140$126
- LIBTAYO$123
- CoolSeal Generator$111
- Harmonic$108
- Echelon Flex$108
- Megadyne$108
How this compares
$4,492 in reported general payments places this provider in the 60th percentile of 24 surgical oncology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 15 | $5,665 |
| Oxycodone Hcl | 38 | $125 |
| Methocarbamol | 22 | $124 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Saint Louis
- Peter DipascoSaint Louis$247K
- Trang NguyenSaint Louis$11K
- Rebecca AftSaint Louis$9K
- Julie MargenthalerSaint Louis$8K
- Taylor BrownSaint Louis$5K
- Jennifer KellerSaint Louis$1K
- Ashley WilbersSaint Louis$1K
- Ashton BrooksSaint Louis$1K
- William GillandersSaint Louis$909
- Ryan FieldsSaint Louis$385
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.